Document Type: Original Articles

Authors

1 Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran;

2 Yasuj Health Center, Yasuj University of Medical Sciences, Yasuj, Iran;

3 Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran;

4 Shiraz University of Medical Sciences, Shiraz, Iran;

5 HIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: Cancer is the third cause of death in Iran and its incidence is rising alarmingly. However, a study reported that Kohgilooyeh and Boyerahmad (a small province in Iran) seems to have substantially lower incidence rate of cancer compared to the other parts of the country. This study is conducted to investigate the epidemiological features of cancer regarding three key factors (sex, age and sites of cancer). Methods: The data collection strategy for this study is similar to the Iranian National Cancer Registry programme. Results: For the study period (2007-2009), 660 eligible cases of cancer were reported to Kohgilooyeh and Boyerahmad’s National Cancer Registry provincial office with average annual age standardized rate (ASR)=64.58 per 100000 (74.95 per 100000 and 45.85 per 100000 for men and women, respectively). The five leading primary cancer sites for both genders in K and B are skin, stomach, blood, bladder and breast. Regarding the sex specific incidence rates of cancer, the skin, stomach, bladder, blood and prostate in men and the skin, breast, stomach, blood and ovary in women are suggested to be the five leading sites of cancer. The trends of age-site specific incidence rates of skin cancer obtained in the current study are essentially similar to what is expected. Conclusion: Compared to the national and international figures, significant differences were found in the age-site specific rates of cancer in the province.

Keywords

  1. Mousavi SM, Gouya MM, Ramazani R, Davanlou
  2. M, Hajsadeghi N, Seddighi Z. Cancer incidence and
  3. mortality in Iran. Ann Oncol 2009; 20(3): 556-63.
  4. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari
  5. R. Epidemiology and molecular genetics of colorectal
  6. cancer in Iran: a review. Arch Iran Med 2009; 12(2):
  7. -9.
  8. Babaei M, Jaafarzadeh H, Sadjadi AR, Samadi F,
  9. Yazdanbod A, Fallah M, et al. Cancer incidence and
  10. mortality in Ardabil: Report of an ongoing populationbased
  11. cancer registry in Iran, 2004-2006. Iranian J Publ
  12. Health, 2009; 38(4): 35-45.
  13. Mehrdad R. Health system in Iran. JMAJ 2009; 52(1):
  14. -73.
  15. Etemadi A, Sadjadi A, Semnani Sh, Nouraie SM,
  16. Khademi H, Bahadori M. Cancer registry in Iran: a
  17. brief overview. Arch Iranian Med 2008; 11(5): 577-80.
  18. S.C.I, Official report on Iranian census. 2011, Statistical
  19. Center of Iran.
  20. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG,
  21. et al. Cancer Statistics in Korea: Incidence, Mortality,
  22. Survival, and Prevalence in 2009. Cancer Res Treat
  23. ; 44(1): 11-24.
  24. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.
  25. Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4):
  26. -49.